Royalty Pharma PLC（RPRX）價格預測RPRXRoyalty Pharma PLC

Alphio's RPRX stock price prediction model matches the current Royalty Pharma PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $64.98 (+0.34%). The 1-week path is $65.76 (+1.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Royalty Pharma PLC is a good buy right now due to its current price of $63.86 being below the average analyst price target of $66, suggesting a potential upside of approximately 3.5%. Additionally, the company has shown strong financial performance with a year-to-date change of +64.33% and a robust gross margin of 100%. The main risk is the high RSI of 82.353, indicating that the stock may be overbought in the short term, which could lead to volatility.

Royalty Pharma PLC (RPRX) last closed at $64.7600021, gaining +1.41%. These facts feed the 1-day and 1-week RPRX price prediction above.